Blocking critical signaling pathways in HCC, such as STAT3/VEGF/HIF-1α.Prevent tumor growth and angiogenesis.Cell cycle arrest, especially in the S phase. This evidence concerns the gene VEGFA and hepatocellular carcinoma.